Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. 1977

W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky

Previous studies from this laboratory demonstrated that secondary hyperparathyroidism in dogs with chronic renal disease may occur, at least in part, as a consequence of the need for progressive adaptation in renal phosphorus (P) excretion that occurs as glomerular filtration rate falls. However, the studies were of relatively short duration. Moreover, no information emerged regarding a potential role of calcium malabsorption in the pathogenesis of secondary hyperparathyroidism. The short duration of the protocol did not lend itself to the study of the effect of P control or the administration of vitamin D in the pathogenesis of renal osteodystrophy. In the present studies, 14 dogs with experimental chronic renal disease were studied serially for a period of 2 yr. Each animal was studied first with two normal kidneys on an intake of P of 1,200 mg/day. Then, renal insufficiency was produced by 5/6 nephrectomy. The dogs then were divided into three groups. In group I, 1,200 mg/day P intake was administered for the full 2 yr. In group II, P intake was reduced from the initial 1,200 mg/day, in proportion to the measured fall in glomerular filtration rate, in an effort to obviate the renal adaptation in P excretion. In group III, "proportional reduction" of P intake also was employed; but in addition, 20 mug of 25(OH)D(3) were administered orally three times a week. In group I, parathyroid hormone (PTH) levels rose throughout the 2-yr period reaching a final concentration of 557+/-70 U (normal 10-60). In group II, values for PTH remained normal throughout the 1st yr, increased modestly between the 12th and the 18th mo, but then did not rise after the 18th mo. In group III, no elevation of PTH levels was observed at any time; however, these animals were hypercalcemic. Histomorphologic analyses of the ribs of these dogs were performed serially throughout the 2-yr period. A linear relationship was obtained between the osteoclastic resorption surface and the concentration of circulating immunoreactive PTH. The osteoid volume was greater in group I animals when compared to those in group II. None of the morphologic abnormalities associated with renal osteodystrophy were observed in the animals in the third group.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration

Related Publications

W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
April 1977, Lancet (London, England),
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
September 1975, The Journal of clinical investigation,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
November 1970, Archives of internal medicine,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
November 1979, The International journal of artificial organs,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
February 1979, Kidney international,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
February 1982, Mineral and electrolyte metabolism,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
May 1977, Calcified tissue research,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
October 1977, British medical journal,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
September 1977, British medical journal,
W E Rutherford, and P Bordier, and P Marie, and K Hruska, and H Harter, and A Greenwalt, and J Blondin, and J Haddad, and N Bricker, and E Slatopolsky
May 1977, Calcified tissue research,
Copied contents to your clipboard!